China’s NHC Sets Sights on Enhancing Grassroots Drug Management and Access
The National Health Commission (NHC) has issued a set of opinions designed to accelerate the...
Policy / Regulatory
NMPA Launches ‘Medical Service Price Items’ Column with Comprehensive Sub-Sections
The National Medical Products Administration (NMPA) has taken a significant step towards enhancing transparency in...
NMPA’s CDE Issues Guidelines for Leveraging Real-World Data in Drug Regulation
The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has released...
Merck Secures Exclusive Rights to LaNova’s PD-1/VEGF Bispecific Antibody LM-299
US pharmaceutical giant Merck, Sharp & Dohme Inc. (MSD; NYSE: MRK) has announced a significant...
China Releases Comprehensive AI Application Guidelines for Healthcare Industry
The National Health Commission, National Administration of Traditional Chinese Medicine, and National Bureau of Disease...
NMPA Issues Interim Provisions for Overseas MAHs’ Designated Domestic Responsible Persons
The National Medical Products Administration (NMPA) has released the “Interim Provisions on the Management of...
NHSA and MoF Announce Medical Insurance Fund Prepayment Initiative to Aid Healthcare Institutions
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly issued...
CDE Releases Technical Guidelines for Pilot Registration and Phased Manufacturing of ADCs
The Center for Drug Evaluation (CDE) has issued the “Technical Requirements for Pilot Registration and...
NHSA and MCA Boost Medical Assistance with Enhanced Information Sharing Measures
The National Healthcare Security Administration (NHSA) and the Ministry of Civil Affairs (MCA) have jointly...
China’s NHC Announces Initiative to Boost Gerontology Medical Services
The National Health Commission (NHC) has issued a notification aimed at enhancing gerontology medical service...
NMPA Draft Proposal Aims to Strengthen Supervision of Drug Entrusted Manufacturing
The National Medical Products Administration (NMPA) has released a draft proposal titled “Announcement on Strengthening...
China’s NMPA Issues Guidelines for Domestic Manufacturing of Imported Medical Devices
The National Medical Products Administration (NMPA) has released a notification aimed at further clarifying the...
China’s National Allied Procurement Office Launches 10th VBP Tender Round Information Filing
The National Allied Procurement Office has released a notification initiating the information filing process for...
NMPA Releases 84th Batch of Reference Drugs for GQCE and First Batch Stripped of Status
The National Medical Products Administration (NMPA) has released the 84th batch of reference drugs for...
China’s CDE Releases 88th Batch of Reference Preparations for Generic Drug Evaluation
The Center for Drug Evaluation (CDE) in China has announced its 88th batch of reference...
National Reimbursement Drug List (NRDL) Negotiations Conclude with Lower Generic Drug Approval Rate
The National Reimbursement Drug List (NRDL) negotiations for the year have concluded, with less than...
NMPA’s CDE Prioritizes Marketing Filings for Innovative Drugs with Priority Review Status
The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) released a...
China’s Pharmaceutical Trade Reaches USD 147.491 Billion in First Three Quarters, Export Growth Outpaces Imports
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...
Jiangxi Province to Implement Direct Medical Insurance Fund Payments for NRDL Drugs from December 2024
The Jiangxi Province Healthcare Security Administration and the Jiangxi Provincial Department of Finance have jointly...
China’s NHSA Sets October Dates for National Reimbursement Drug List Negotiations and Price Bidding
The National Healthcare Security Administration (NHSA) has announced that the one-site negotiation and price bidding...